BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma.

Abstract:

:Despite major advances in the treatment of metastatic melanoma, treatment failure is still inevitable in most cases. Manipulation of key epigenetic regulators, including inhibition of Bromodomain and extra-terminal domain (BET) family members impairs cell proliferation in vitro and tumor growth in vivo in different cancers, including melanoma. Here, we investigated the effect of combining the BET inhibitor JQ1 with the BRAF inhibitor Vemurafenib in in vitro and in vivo models of BRAF-mutant melanoma. We performed cytotoxicity and apoptosis assays, and a xenograft mouse model to determine the in vitro and in vivo efficacy of JQ1 in combination with Vemurafenib against BRAF-mutant melanoma cell lines. Further, to investigate the molecular mechanisms underlying the effects of combined treatment, we conducted antibody arrays of in vitro drug-treated cell lines and RNA sequencing of drug-treated xenograft tumors. The combination of JQ1 and Vemurafenib acted synergistically in BRAF-mutant cell lines, resulting in marked apoptosis in vitro, with upregulation of proapoptotic proteins. In vivo, combination treatment suppressed tumor growth and significantly improved survival compared to either drug alone. RNA sequencing of tumor tissues revealed almost four thousand genes that were uniquely modulated by the combination, with several anti-apoptotic genes significantly down-regulated. Collectively, our data provide a rationale for combined BET and BRAF inhibition as a novel strategy for the treatment of melanoma.

journal_name

Cancer Med

journal_title

Cancer medicine

authors

Paoluzzi L,Hanniford D,Sokolova E,Osman I,Darvishian F,Wang J,Bradner JE,Hernando E

doi

10.1002/cam4.667

subject

Has Abstract

pub_date

2016-06-01 00:00:00

pages

1183-93

issue

6

issn

2045-7634

journal_volume

5

pub_type

杂志文章
  • Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and pancreatic cancer incidence and mortality: A prospective cohort study.

    abstract:BACKGROUND:Whether adherence to the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations is associated with a reduced risk of pancreatic cancer remains controversial. Additionally, no study has investigated this association in the US population. Hence, we inves...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.3348

    authors: Zhang ZQ,Li QJ,Hao FB,Wu YQ,Liu S,Zhong GC

    更新日期:2020-09-01 00:00:00

  • miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4.

    abstract:PURPOSE:To investigate the effect of miR-107 on the growth and metastasis of gastric cancer (GC) and elucidate the probable mechanisms. METHODS:The expression of miR-107 and FAT4 in GC tissues and cells were detected using qRT-PCR. Bioinformatics and dual luciferase reporter gene assays were used to analyze the relati...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2396

    authors: Wang L,Li K,Wang C,Shi X,Yang H

    更新日期:2019-09-01 00:00:00

  • CircSMC3 regulates gastric cancer tumorigenesis by targeting miR-4720-3p/TJP1 axis.

    abstract::Circular RNAs (circRNAs) are identified to play an evident role in many human cancers, such as gastric cancer. However, the potential mechanisms underlying the circRNA-induced pathogenesis in gastric cancers are still elusive. The present study is designed to unfold the mechanism by which circRNAs involve in gastric c...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.3057

    authors: Xia T,Pan Z,Zhang J

    更新日期:2020-06-01 00:00:00

  • Comparative effectiveness of radiotherapy for early-stage hormone receptor-positive breast cancer in elderly women using real-world data.

    abstract:BACKGROUND:Radiotherapy is the recommended treatment after breast-conserving surgery (BCS) for early-stage breast cancer (BC). However, there is no clear evidence whether radiotherapy after BCS improves the survival of elderly women diagnosed with early-stage hormone receptor-positive (HR+) BC. The aim of this study wa...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.1904

    authors: Ali AA,Tawk R,Xiao H,Campbell E,Semykina A,Montero AJ,Mogos M,Diaby V

    更新日期:2019-01-01 00:00:00

  • Treatment-related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity-modulated versus conformal radiation therapy.

    abstract::Intensity-modulated radiation therapy (IMRT) is frequently utilized after prostatectomy without strong evidence for an improvement in outcomes compared to conformal radiation therapy (RT). We analyzed a large group of patients treated with RT after radical prostatectomy (RP) to compare complications after IMRT and CRT...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.205

    authors: Crandley EF,Hegarty SE,Hyslop T,Wilson DD,Dicker AP,Showalter TN

    更新日期:2014-04-01 00:00:00

  • The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma.

    abstract::Nuclear receptor coactivator 1 (NCOA1) plays crucial roles in the regulation of gene expression mediated by a wide spectrum of steroid receptors such as androgen receptor (AR), estrogen receptor α (ER α), and estrogen receptor β (ER β). Therefore, dysregulations of NCOA1 have been found in a variety of cancer types. H...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.1786

    authors: Wang L,Li W,Li K,Guo Y,Liu D,Yao Z,Lin X,Li S,Jiang Z,Liu Q,Jiang Y,Zhang B,Chen L,Zhou F,Ren H,Lin D,Zhang D,Yeung SJ,Zhang H

    更新日期:2018-10-01 00:00:00

  • Role of alternative splicing signatures in the prognosis of glioblastoma.

    abstract:BACKGROUND:Increasing evidence has validated the crucial role of alternative splicing (AS) in tumors. However, comprehensive investigations on the entirety of AS and their clinical value in glioblastoma (GBM) are lacking. METHODS:The AS profiles and clinical survival data related to GBM were obtained from The Cancer G...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2666

    authors: Xie ZC,Wu HY,Dang YW,Chen G

    更新日期:2019-12-01 00:00:00

  • Incidence and survival for oropharynx and non-oropharynx head and neck cancers among veterans living with HIV.

    abstract:BACKGROUND:People living with HIV/AIDS (PLWH) have an excess risk for head and neck squamous cell carcinoma (HNSCC) compared to the general U.S. population, but little is known about HIV-specific risk factors associated with the incidence and outcomes HNSCC. We aim to identify clinical and HIV-specific risk factors ass...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.3539

    authors: Mazul AL,Hartman C,Kramer J,White DL,Royse K,Raychaudhury S,Sandulache V,Ahmed ST,Richardson P,Sikora AG,Chiao E

    更新日期:2020-12-01 00:00:00

  • DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.

    abstract:BACKGROUND:Downstream of tyrosine kinase 6 (DOK6), which is specifically expressed in the nervous system, was previously recognized as an adapter only in neurite outgrowth. Recent studies also demonstrated the potential role of DOK6 in solid tumors such as gastric cancer and breast cancer. However, previous studies of ...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2540

    authors: Sun GK,Tang LJ,Zhou JD,Xu ZJ,Yang L,Yuan Q,Ma JC,Liu XH,Lin J,Qian J,Yao DM

    更新日期:2019-10-01 00:00:00

  • Long noncoding RNA MSC-AS1 promotes hepatocellular carcinoma oncogenesis via inducing the expression of phosphoglycerate kinase 1.

    abstract:BACKGROUND AND OBJECTIVES:Increasing studies report that lncRNAs are dysregulated in hepatocellular carcinoma (HCC), which might function as significant diagnostic biomarkers of HCC. LncRNA MSC-AS1 has been newly discovered in several cancers. However, its biological effect in HCC remains to be clearly elucidated. The ...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.3080

    authors: Cao C,Zhong Q,Lu L,Huang B,Li J,Meng L,Wei H

    更新日期:2020-07-01 00:00:00

  • Three-year outcomes of a once daily fractionation scheme for accelerated partial breast irradiation (APBI) using 3-D conformal radiotherapy (3D-CRT).

    abstract::The aim of this study was to report 3-year outcomes of toxicity, cosmesis, and local control using a once daily fractionation scheme (49.95 Gy in 3.33 Gy once daily fractions) for accelerated partial breast irradiation (APBI) using three-dimensional conformal radiotherapy (3D-CRT). Between July 2008 and August 2010, w...

    journal_title:Cancer medicine

    pub_type: 临床试验,杂志文章

    doi:10.1002/cam4.157

    authors: Goyal S,Daroui P,Khan AJ,Kearney T,Kirstein L,Haffty BG

    更新日期:2013-12-01 00:00:00

  • Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer Database.

    abstract::For elderly patients with glioblastoma multiforme (GBM), randomized trials have shown similar survival with hypofractionated short-course radiotherapy (SCRT) compared to conventionally fractionated long-course radiotherapy (LCRT). We evaluated the adoption of SCRT along with associated factors and survival in a nation...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.1070

    authors: Mak KS,Agarwal A,Qureshi MM,Truong MT

    更新日期:2017-06-01 00:00:00

  • Antitumor activity of a 5T4 targeting antibody drug conjugate with a novel payload derived from MMAF via C-Lock linker.

    abstract::Antibody-drug conjugates (ADCs) belong to a promising class of biopharmaceuticals in which target-killing of tumor cells was achieved by marrying the potency of the cytotoxic payload with the tumor specificity of the antibody. Here we developed a novel ADC (ZV0508) that targets 5T4 oncofetal antigen, which is overexpr...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2066

    authors: Shi B,Wu M,Li Z,Xie Z,Wei X,Fan J,Xu Y,Ding D,Akash SH,Chen S,Cao S

    更新日期:2019-04-01 00:00:00

  • Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer.

    abstract::Patients were identified from a population-based prospective study of 4990 individuals with symptoms associated with colorectal cancer (CRC). A total of 244 CRC tissue samples were available for immunohistochemical staining of uPAR, semiquantitatively scored at the invasive front, and in the tumor core on cancer cells...

    journal_title:Cancer medicine

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cam4.242

    authors: Illemann M,Laerum OD,Hasselby JP,Thurison T,Høyer-Hansen G,Nielsen HJ,Danish Study Group on Early Detection of Colorectal Cancer.,Christensen IJ

    更新日期:2014-08-01 00:00:00

  • Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers.

    abstract::Preoperative use of metformin in obese women with endometrioid endometrial cancer (EEC) reduces tumor proliferation and inhibits the mammalian target of rapamycin pathway, though is only effective in select cases. This study sought to identify a predictive and/or pharmacodynamic proteomic signature of metformin respon...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2729

    authors: Bateman NW,Teng PN,Hope E,Hood BL,Oliver J,Ao W,Zhou M,Wang G,Tommarello D,Wilson K,Litzy T,Conrads KA,Hamilton CA,Darcy KM,Casablanca Y,Maxwell GL,Bae-Jump V,Conrads TP

    更新日期:2020-02-01 00:00:00

  • Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer.

    abstract::The role of stereotactic body radiation therapy for the elderly with advanced or medically inoperable pancreatic cancer was still debated. Therefore, we evaluated the value of stereotactic body radiation therapy and its association with survival of those patients. A total of 417 elderly patients were retrospectively r...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.1164

    authors: Zhu X,Li F,Ju X,Cao F,Cao Y,Fang F,Qing S,Shen Y,Jia Z,Zhang H

    更新日期:2017-10-01 00:00:00

  • HER2 and GATA4 are new prognostic factors for early-stage ovarian granulosa cell tumor-a long-term follow-up study.

    abstract::Granulosa cell tumors (GCTs) carry a risk of recurrence also at an early stage, but reliable prognostic factors are lacking. We assessed clinicopathological prognostic factors and the prognostic roles of the human epidermal growth factor receptors (HER 2-4) and the transcription factor GATA4 in GCTs. We conducted a lo...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.230

    authors: Färkkilä A,Andersson N,Bützow R,Leminen A,Heikinheimo M,Anttonen M,Unkila-Kallio L

    更新日期:2014-06-01 00:00:00

  • Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization.

    abstract::Toward developing a model system for investigating the role of the microenvironment in the radioresistance of glioblastoma (GBM), human glioblastoma stem-like cells (GSCs) were grown in coculture with human astrocytes. Using a trans-well assay, survival analyses showed that astrocytes significantly decreased the radio...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.510

    authors: Rath BH,Wahba A,Camphausen K,Tofilon PJ

    更新日期:2015-11-01 00:00:00

  • Patterns and predictors of self-reported clinical diagnosis and treatment for depression in prostate cancer survivors.

    abstract:BACKGROUND:Appropriate depression care is a cancer-care priority. However, many cancer survivors live with undiagnosed and untreated depression. Prostate cancer survivors may be particularly vulnerable, but little is known about their access to depression care. The goal of this study was to describe patterns and predic...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2239

    authors: Erim DO,Bensen JT,Mohler JL,Fontham ETH,Song L,Farnan L,Delacroix SE,Peters ES,Erim TN,Chen RC,Gaynes BN

    更新日期:2019-07-01 00:00:00

  • Primary bone marrow lymphoma: A hematological emergency in adults with fever of unknown origin.

    abstract::Primary bone marrow lymphoma (PBML) represents non-Hodgkin lymphoma (NHL) that primarily arises in the bone marrow (BM) without lymphadenopathy. This condition has various definitions and can be masked by prolonged fever, leading to delayed diagnosis. We aimed to identify clinical features and risk indicators of PBML....

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.1669

    authors: Wang HY,Yang CF,Chiou TJ,Gau JP,Chen PM,Tsai CY,Hsu HC,Wang FD,Liu JH,Hsiao LT

    更新日期:2018-08-01 00:00:00

  • Sex-dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial.

    abstract::The least toxic time (LTT) of irinotecan varied by up to 8 hours according to sex and genetic background in mice. The translational relevance was investigated within a randomized trial dataset, where no LTT stood out significantly in the whole population. 130 male and 63 female eligible patients with metastatic colore...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.3056

    authors: Innominato PF,Ballesta A,Huang Q,Focan C,Chollet P,Karaboué A,Giacchetti S,Bouchahda M,Adam R,Garufi C,Lévi FA

    更新日期:2020-06-01 00:00:00

  • Delayed presentation, diagnosis, and psychosocial aspects of male breast cancer.

    abstract:INTRODUCTION:Male breast cancer is uncommon, delay in seeking medical attention often results in late presentation and poor prognosis. METHODS:Retrospective review of a prospectively maintained database was performed. Patients who were still having regular follow-up were contacted for telephone interview. RESULTS:In ...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2953

    authors: Co M,Lee A,Kwong A

    更新日期:2020-05-01 00:00:00

  • Do doctors who order more routine medical tests diagnose more cancers? A population-based study from Ontario Canada.

    abstract:BACKGROUND:The overuse of medical tests leads to higher costs, wasting of resources, and the potential for overdiagnosis of disease. This study was designed to determine whether the patients of family doctors who order more routine medical tests are diagnosed with more cancers. METHOD:A retrospective population-based ...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.1925

    authors: Hall SF,Webber C,Groome PA,Booth CM,Nguyen P,DeWit Y

    更新日期:2019-02-01 00:00:00

  • Transformation Scoring System (TSS): A new assessment index for clinical transformation of follicular lymphoma.

    abstract::Although histologic analysis is the gold standard for diagnosing follicular lymphoma (FL) transformation, many patients are diagnosed with transformation by clinical factors as biopsy specimens often cannot be obtained. Despite the frequency of clinical diagnosis, no clinical assessment tool has yet been established f...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.3501

    authors: Shichijo T,Maruyama D,Yamauchi N,Maeshima AM,Sugano M,Yuda S,Tajima K,Kurihara H,Shimada K,Suzuki T,Toyoda K,Makita S,Fukuhara S,Munakata W,Suzuki T,Kobayashi Y,Taniguchi H,Minami Y,Izutsu K,Tobinai K

    更新日期:2020-12-01 00:00:00

  • Cumulative evidence for association between genetic polymorphisms and esophageal cancer susceptibility: A review with evidence from meta-analysis and genome-wide association studies.

    abstract::An increasing number of publications had reported the association between single-nucleotide polymorphisms (SNPs) and esophageal cancer (EC) risk in the past decades. Results from these publications were controversial. We used PubMed, Medline, and Web of Science to identify meta-analysis articles published before 30 Ju...

    journal_title:Cancer medicine

    pub_type: 杂志文章,meta分析,评审

    doi:10.1002/cam4.1972

    authors: Tian J,Liu C,Liu G,Zuo C,Chen H

    更新日期:2019-03-01 00:00:00

  • Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling.

    abstract:BACKGROUND:Cancer of unknown primary (CUP) is a distinct clinicopathological entity with poor prognosis, frequently resistant to chemotherapy. Comprehensive genomic profiling (CGP) by next-generation sequencing potentially identifies novel treatment options for CUP patients. The objective of this study was to determine...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.1689

    authors: Binder C,Matthes KL,Korol D,Rohrmann S,Moch H

    更新日期:2018-09-01 00:00:00

  • Tamoxifen is a candidate first-in-class inhibitor of acid ceramidase that reduces amitotic division in polyploid giant cancer cells-Unrecognized players in tumorigenesis.

    abstract::Polyploid giant cancer cells (PGCC) represent a poorly understood, small subpopulation of tumor cells that are increasingly being recognized for their critical role in therapy resistance, metastasis, and cancer recurrence. PGCC have the potential to generate progeny through primitive or cleavage-like division, which a...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2960

    authors: White-Gilbertson S,Lu P,Jones CM,Chiodini S,Hurley D,Das A,Delaney JR,Norris JS,Voelkel-Johnson C

    更新日期:2020-05-01 00:00:00

  • Distinctive lung cancer incidence trends among men and women attributable to the period effect in Shanghai: An analysis spanning 42 years.

    abstract:BACKGROUND:Many previous studies reported secular trend of lung cancer incidence and mortality, but little is known about the possible reasons for these trends. METHODS:Data were obtained from Shanghai Cancer Registry. Age-standardized rates were calculated and average annual percent changes (AAPCs) were evaluated by ...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2917

    authors: Xie L,Qian Y,Liu Y,Li Y,Jia S,Yu H,Wang C,Qian B,Bao P

    更新日期:2020-04-01 00:00:00

  • LncRNA NUTM2A-AS1 positively modulates TET1 and HIF-1A to enhance gastric cancer tumorigenesis and drug resistance by sponging miR-376a.

    abstract::Long noncoding RNA NUTM2A-AS1 has been shown to be dysregulated in non-small cell lung carcinoma. To date, it is unclear whether NUTM2A-AS1 plays a role in gastric cancer progression. The purpose of this study is to elucidate the molecular mechanism of the role of NUTM2A-AS1 in gastric cancer. mRNA and protein levels ...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.3544

    authors: Wang J,Yu Z,Wang J,Shen Y,Qiu J,Zhuang Z

    更新日期:2020-12-01 00:00:00

  • CCN1 stimulated the osteoblasts via PTEN/AKT/GSK3β/cyclinD1 signal pathway in Myeloma Bone Disease.

    abstract:BACKGROUNDS:Myeloma-related bone disease (MBD) is a common complication of multiple myeloma (MM), which can both decrease life quality and influence the prognosis of the patients. We have found that CCN1 stimulated proliferation and differentiation of osteoblasts in MM in vitro and in vivo, while its mechanism still re...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2608

    authors: Yan S,Liu H,Liu Z,Peng F,Jiang F,Li L,Fu R

    更新日期:2020-01-01 00:00:00